ClinConnect ClinConnect Logo
Search / Trial NCT06961799

Validating a Multifactorial Algorithm to Predict Fall Risk in Community Dwelling Older Persons Aged 65 Years or Older

Launched by UNIVERSITY GHENT · May 5, 2025

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new way to predict the risk of falls in older adults living in the community, specifically those aged 65 and older. Falls are common among this age group, affecting about 23% to 34% of them each year. The researchers aim to improve fall prevention by using a new, comprehensive screening tool that will help identify individuals who are at higher risk for falls. They will compare the effectiveness of this new method with existing practices in Belgium to see how well it works.

To participate, you must be 65 years or older, live independently, and be able to walk on your own, possibly with a walking aid. Those who have had surgery in the last six months or have worsening health issues related to existing conditions will not be eligible. Participants will complete a one-time assessment that includes answering questions about their health and completing some physical tests. After this, they will keep a monthly calendar to track if they fall. This information will help researchers understand how well the new prediction tool works.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 65years or older
  • community dwellers
  • absence of surgery or exacerbation of symptoms in the last 6 months
  • ability to stand and walk independently (alone), possibly with an walking aid.
  • Exclusion Criteria:
  • \<65 years of age
  • surgery within the previous 6 months affecting gait and mobility
  • exacerbation of symptoms coming from a diagnosed disease
  • older adults with insufficient (language) comprehension to complete the tests and questionnaires

About University Ghent

University Ghent is a prestigious Belgian research institution renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a multidisciplinary approach, the university fosters collaboration among leading experts in various fields, ensuring rigorous study design and ethical standards. University Ghent is dedicated to exploring new therapeutic modalities and enhancing healthcare outcomes, making significant contributions to both local and global health landscapes. Its state-of-the-art facilities and emphasis on research excellence position it as a pivotal sponsor in the realm of clinical research.

Locations

Ghent, East Flanders, Belgium

Patients applied

0 patients applied

Trial Officials

Dirk Cambier, Prof. Dr.

Principal Investigator

University Ghent

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported